Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation for PH on December 4, 2025 10:29AM ET. The previous analyst recommendation was Overweight.PH was trading at $869.2 at issue of the analyst...

December 4, 2025   PH 0.55%

Barclays analyst issues OVERWEIGHT recommendation for GEV on December 4, 2025 10:29AM ET. The previous analyst recommendation was Overweight.GEV was trading at $601.97 at issue of the analyst...

December 4, 2025   GEV -1.18%

Barclays analyst issues OVERWEIGHT recommendation for NVT on December 4, 2025 10:29AM ET. The previous analyst recommendation was Overweight.NVT was trading at $104.97 at issue of the analyst...

December 4, 2025   NVT 0.69%

Barclays analyst issues OVERWEIGHT recommendation for MMM on December 4, 2025 10:30AM ET. The previous analyst recommendation was Overweight.MMM was trading at $173.09 at issue of the analyst...

December 4, 2025   MMM 1.02%

Barclays analyst issues OVERWEIGHT recommendation for TT on December 4, 2025 10:30AM ET. The previous analyst recommendation was Overweight.TT was trading at $409.07 at issue of the analyst...

December 4, 2025   TT 0.41%

Barclays analyst issues NEUTRAL recommendation for VRT on December 4, 2025 10:30AM ET. The previous analyst recommendation was Neutral.VRT was trading at $178.88 at issue of the analyst...

December 4, 2025   VRT -1.26%

Citigroup analyst issues OUTPERFORM recommendation for GENI on December 4, 2025 10:53AM ET. The previous analyst recommendation was Outperform.GENI was trading at $11.32 at issue of the analyst...

December 4, 2025   GENI -2.68%

Wolfe Research analyst issues OUTPERFORM recommendation for CR on December 4, 2025 10:41AM ET. CR was trading at $184.03 at issue of the analyst recommendation.The overall analyst consensus...

December 4, 2025   CR 0.71%

Wells Fargo analyst issues OVERWEIGHT recommendation for MAZE on December 4, 2025 10:32AM ET. MAZE was trading at $41.49 at issue of the analyst recommendation.The overall analyst consensus...

December 4, 2025   MAZE -0.72%

Citigroup analyst issues BUY recommendation for ORCL on December 4, 2025 10:39AM ET. The previous analyst recommendation was Buy.ORCL was trading at $207.73 at issue of the analyst...

December 4, 2025   ORCL 2.11%